Organon & Co.

New Jersey
Consumer Services, Health Care Equipment and Services

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Caution
Medium Risk


Organon & Co., a global healthcare company, does not provide viewpoint protections for its employees. However, it has not publicly terminated business relationships based on views or beliefs. By complying with Human Rights Campaign’s controversial demands, Organon increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children. Organon uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company integrates ESG into its business practices and is a corporate partner of the NGLCC. Organon signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. For these reasons, Organon & Co. receives a Medium Risk rating.

View Full Report
Generate Reports